创伤外科杂志
創傷外科雜誌
창상외과잡지
JOURNAL OF AUMATIC SURGERY
2013年
5期
428-429
,共2页
赵兵清%周利江%兰振文%王静
趙兵清%週利江%蘭振文%王靜
조병청%주리강%란진문%왕정
四肢损伤%肌肉%缺血%左卡尼汀
四肢損傷%肌肉%缺血%左卡尼汀
사지손상%기육%결혈%좌잡니정
limbs injury%muscle%ischemia%levocarnitine
目的观察静脉补充左卡尼汀对四肢肌肉缺血性病变的治疗效果。方法63例四肢肌肉缺血性病变患者根据入院时间分为二组,对照组(30例),2006年1月~2008年12月入院后给予常规治疗;治疗组(33例),2009年1月~2012年6月在对照组治疗的基础上给予左卡尼汀治疗。测量两组术后治疗第3天和第5天后血清肌酸磷酸激酶浓度降低程度。结果治疗组血清肌酸磷酸激酶下降均值分别为:1800.17(U/L)和2330.08(U/L);对照组血清肌酸磷酸激酶下降均值分别为:1245.48(U/L)和1620.74(U/L),两组血清肌酸磷酸激酶在第3d和第5d下降均值差异均有统计学意义(P<0.01)。结论左卡尼汀对四肢肌肉缺血性病变有明显的改善作用。
目的觀察靜脈補充左卡尼汀對四肢肌肉缺血性病變的治療效果。方法63例四肢肌肉缺血性病變患者根據入院時間分為二組,對照組(30例),2006年1月~2008年12月入院後給予常規治療;治療組(33例),2009年1月~2012年6月在對照組治療的基礎上給予左卡尼汀治療。測量兩組術後治療第3天和第5天後血清肌痠燐痠激酶濃度降低程度。結果治療組血清肌痠燐痠激酶下降均值分彆為:1800.17(U/L)和2330.08(U/L);對照組血清肌痠燐痠激酶下降均值分彆為:1245.48(U/L)和1620.74(U/L),兩組血清肌痠燐痠激酶在第3d和第5d下降均值差異均有統計學意義(P<0.01)。結論左卡尼汀對四肢肌肉缺血性病變有明顯的改善作用。
목적관찰정맥보충좌잡니정대사지기육결혈성병변적치료효과。방법63례사지기육결혈성병변환자근거입원시간분위이조,대조조(30례),2006년1월~2008년12월입원후급여상규치료;치료조(33례),2009년1월~2012년6월재대조조치료적기출상급여좌잡니정치료。측량량조술후치료제3천화제5천후혈청기산린산격매농도강저정도。결과치료조혈청기산린산격매하강균치분별위:1800.17(U/L)화2330.08(U/L);대조조혈청기산린산격매하강균치분별위:1245.48(U/L)화1620.74(U/L),량조혈청기산린산격매재제3d화제5d하강균치차이균유통계학의의(P<0.01)。결론좌잡니정대사지기육결혈성병변유명현적개선작용。
Objective To investigate the therapeutic effects of the intravenous usage of levocarnitine in treating patients with limb muscle ischemia . Methods Sixty-three patients were divided into two groups by the time of admission .Thirty patients in the control group were treated with conventional therapy of limb muscle ische -mia;thirty-three patients in the treatment group were treated with intravenous usage of levocarnitine and conventional therapy.The degrading levels of the concentration of creatine phosphokinase in blood serum of all patients were measured at third day and fifth day after operation .Results The mean degrading level of the concentration of crea-tine phosphokinase in blood serum of the treatment group was 1800.17(U/L)and 2330.08(U/L),and the mean degrading level of the concentration of creatine phosphokinase in blood serum of the control group was 1245.48( U/L)and 1620.74(U/L).There was statistical significance in the difference of the mean degrading level at the third day and the fifth day between the two groups (P<0.01).Conclusion Levocarnitine can significantly improve the condition of limb muscle ischemia .